Total Liabilities Summary of Biogen Inc.

Biogen Inc.'s latest annual total liabilities in 2023 was 12.04 Billion USD , up 7.88% from previous year.
Biogen Inc.'s latest quarterly total liabilities in 2024 Q3 was 11.21 Billion USD , up 9.52% from previous quarter.
Biogen Inc. reported annual total liabilities of 11.16 Billion USD in 2022, down -13.56% from previous year.
Biogen Inc. reported annual total liabilities of 12.91 Billion USD in 2021, down -7.29% from previous year.
Biogen Inc. reported quarterly total liabilities of 11.35 Billion USD for 2024 Q1, down -5.73% from previous quarter.
Biogen Inc. reported quarterly total liabilities of 11.21 Billion USD for 2024 Q3, up 9.52% from previous quarter.

Annual Total Liabilities Chart of Biogen Inc. (2023 - 1989)

Historical Annual Total Liabilities of Biogen Inc. (2023 - 1989)

Year	Total Liabilities	Total Liabilities Growth
2023	12.04 Billion USD	7.88%
2022	11.16 Billion USD	-13.56%
2021	12.91 Billion USD	-7.29%
2020	13.93 Billion USD	0.27%
2019	13.89 Billion USD	13.36%
2018	12.25 Billion USD	10.88%
2017	11.05 Billion USD	2.85%
2016	10.74 Billion USD	6.1%
2015	10.12 Billion USD	189.22%
2014	3.5 Billion USD	8.02%
2013	3.24 Billion USD	2.41%
2012	3.16 Billion USD	20.73%
2011	2.62 Billion USD	-0.77%
2010	2.64 Billion USD	15.42%
2009	2.28 Billion USD	-14.33%
2008	2.67 Billion USD	-13.62%
2007	3.09 Billion USD	120.56%
2006	1.4 Billion USD	-3.97%
2005	1.46 Billion USD	-37.54%
2004	2.33 Billion USD	-4.54%
2003	2.45 Billion USD	495.44%
2002	411.56 Million USD	10.57%
2001	372.21 Million USD	14.37%
2000	325.45 Million USD	9.05%
1999	298.44 Million USD	44.8%
1998	206.1 Million USD	-25.74%
1997	277.53 Million USD	84.77%
1996	150.2 Million USD	74.21%
1995	86.22 Million USD	79.9%
1994	47.92 Million USD	50.72%
1993	31.8 Million USD	21.37%
1992	26.2 Million USD	85.82%
1991	14.1 Million USD	10.16%
1990	12.8 Million USD	113.33%
1989	6 Million USD	-53.49%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	10.91 Billion USD	-3.87%
2024 Q1	11.35 Billion USD	-5.73%
2024 Q3	11.21 Billion USD	9.52%
2023 Q3	13.71 Billion USD	28.21%
2023 Q2	10.69 Billion USD	-1.06%
2023 Q1	10.81 Billion USD	-3.17%
2023 FY	12.04 Billion USD	7.88%
2023 Q4	12.04 Billion USD	-12.16%
2022 Q2	13.21 Billion USD	6.65%
2022 FY	11.16 Billion USD	-13.56%
2022 Q4	11.16 Billion USD	-7.63%
2022 Q3	12.08 Billion USD	-8.55%
2022 Q1	12.39 Billion USD	-4.06%
2021 FY	12.91 Billion USD	-7.29%
2021 Q2	13.25 Billion USD	0.49%
2021 Q1	13.19 Billion USD	-5.32%
2021 Q4	12.91 Billion USD	-0.06%
2021 Q3	12.92 Billion USD	-2.49%
2020 Q3	14.18 Billion USD	-0.23%
2020 Q1	13.58 Billion USD	-2.25%
2020 FY	13.93 Billion USD	0.27%
2020 Q2	14.22 Billion USD	4.71%
2020 Q4	13.93 Billion USD	-1.81%
2019 Q4	13.89 Billion USD	2.99%
2019 Q1	12.62 Billion USD	2.99%
2019 Q2	13.33 Billion USD	5.67%
2019 Q3	13.49 Billion USD	1.15%
2019 FY	13.89 Billion USD	13.36%
2018 Q1	12.05 Billion USD	9.03%
2018 Q4	12.25 Billion USD	4.47%
2018 Q3	11.73 Billion USD	0.28%
2018 FY	12.25 Billion USD	10.88%
2018 Q2	11.69 Billion USD	-2.93%
2017 Q3	10.22 Billion USD	0.38%
2017 FY	11.05 Billion USD	2.85%
2017 Q1	9.72 Billion USD	-9.49%
2017 Q4	11.05 Billion USD	8.12%
2017 Q2	10.18 Billion USD	4.7%
2016 Q4	10.74 Billion USD	7.59%
2016 Q1	10.34 Billion USD	2.14%
2016 Q2	10.11 Billion USD	-2.28%
2016 Q3	9.99 Billion USD	-1.2%
2016 FY	10.74 Billion USD	6.1%
2015 FY	10.12 Billion USD	189.22%
2015 Q1	3.54 Billion USD	1.36%
2015 Q2	4.18 Billion USD	17.92%
2015 Q3	10.16 Billion USD	142.74%
2015 Q4	10.12 Billion USD	-0.31%
2014 Q4	3.5 Billion USD	7.0%
2014 FY	3.5 Billion USD	8.02%
2014 Q3	3.27 Billion USD	-2.37%
2014 Q2	3.35 Billion USD	8.54%
2014 Q1	3.08 Billion USD	-4.73%
2013 Q2	2.93 Billion USD	4.05%
2013 Q1	2.82 Billion USD	-10.78%
2013 FY	3.24 Billion USD	2.41%
2013 Q4	3.24 Billion USD	3.77%
2013 Q3	3.12 Billion USD	6.3%
2012 Q4	3.16 Billion USD	6.66%
2012 FY	3.16 Billion USD	20.73%
2012 Q2	2.89 Billion USD	3.09%
2012 Q3	2.96 Billion USD	2.66%
2012 Q1	2.8 Billion USD	6.95%
2011 FY	2.62 Billion USD	-0.77%
2011 Q3	2.56 Billion USD	0.11%
2011 Q4	2.62 Billion USD	2.1%
2011 Q2	2.56 Billion USD	-2.04%
2011 Q1	2.61 Billion USD	-0.9%
2010 Q1	2.26 Billion USD	-1.01%
2010 FY	2.64 Billion USD	15.42%
2010 Q3	2.32 Billion USD	1.44%
2010 Q4	2.64 Billion USD	13.73%
2010 Q2	2.29 Billion USD	1.06%
2009 FY	2.28 Billion USD	-14.33%
2009 Q4	2.28 Billion USD	-5.71%
2009 Q3	2.42 Billion USD	-4.06%
2009 Q2	2.53 Billion USD	-0.92%
2009 Q1	2.55 Billion USD	-4.41%
2008 Q4	2.67 Billion USD	-3.39%
2008 FY	2.67 Billion USD	-13.62%
2008 Q3	2.76 Billion USD	4.41%
2008 Q2	2.64 Billion USD	0.45%
2008 Q1	2.63 Billion USD	-14.75%
2007 Q4	3.09 Billion USD	9.59%
2007 FY	3.09 Billion USD	120.56%
2007 Q1	1.36 Billion USD	-2.89%
2007 Q2	4.29 Billion USD	215.54%
2007 Q3	2.82 Billion USD	-34.32%
2006 Q3	1.29 Billion USD	-3.0%
2006 Q4	1.4 Billion USD	8.62%
2006 Q1	1.38 Billion USD	-5.45%
2006 FY	1.4 Billion USD	-3.97%
2006 Q2	1.33 Billion USD	-3.61%
2005 Q2	1.52 Billion USD	-33.28%
2005 Q4	1.46 Billion USD	-3.67%
2005 Q1	2.28 Billion USD	-2.46%
2005 FY	1.46 Billion USD	-37.54%
2005 Q3	1.51 Billion USD	-0.36%
2004 Q3	2.31 Billion USD	0.75%
2004 FY	2.33 Billion USD	-4.54%
2004 Q1	2.31 Billion USD	-5.57%
2004 Q2	2.29 Billion USD	-0.91%
2004 Q4	2.33 Billion USD	1.26%
2003 FY	2.45 Billion USD	495.44%
2003 Q2	328.2 Million USD	-8.12%
2003 Q1	357.21 Million USD	-13.21%
2003 Q3	373.32 Million USD	13.75%
2003 Q4	2.45 Billion USD	556.44%
2002 FY	411.56 Million USD	10.57%
2002 Q4	411.56 Million USD	20.39%
2002 Q3	341.85 Million USD	-5.89%
2002 Q2	363.24 Million USD	3.67%
2002 Q1	350.38 Million USD	-5.87%
2001 FY	372.21 Million USD	14.37%
2001 Q4	372.21 Million USD	5.71%
2001 Q3	352.11 Million USD	5.69%
2001 Q2	333.15 Million USD	2.44%
2001 Q1	325.22 Million USD	-0.07%
2000 FY	325.45 Million USD	9.05%
2000 Q4	325.45 Million USD	-4.8%
2000 Q3	341.85 Million USD	7.48%
2000 Q2	318.06 Million USD	17.01%
2000 Q1	271.82 Million USD	-8.92%
1999 Q1	181.4 Million USD	-11.99%
1999 FY	298.44 Million USD	44.8%
1999 Q4	298.44 Million USD	51.11%
1999 Q3	197.5 Million USD	4.77%
1999 Q2	188.5 Million USD	3.91%
1998 Q1	248.7 Million USD	-10.39%
1998 Q2	214.1 Million USD	-13.91%
1998 Q3	219.8 Million USD	2.66%
1998 Q4	206.1 Million USD	-6.23%
1998 FY	206.1 Million USD	-25.74%
1997 Q1	148.4 Million USD	-1.2%
1997 FY	277.53 Million USD	84.77%
1997 Q2	146 Million USD	-1.62%
1997 Q3	159.4 Million USD	9.18%
1997 Q4	277.53 Million USD	74.11%
1996 Q2	115.5 Million USD	27.34%
1996 FY	150.2 Million USD	74.21%
1996 Q1	90.7 Million USD	5.19%
1996 Q3	126.3 Million USD	9.35%
1996 Q4	150.2 Million USD	18.92%
1995 Q4	86.22 Million USD	19.75%
1995 Q3	72 Million USD	16.13%
1995 Q1	63.7 Million USD	32.91%
1995 FY	86.22 Million USD	79.9%
1995 Q2	62 Million USD	-2.67%
1994 Q3	58.6 Million USD	78.66%
1994 Q1	29.5 Million USD	-7.23%
1994 Q2	32.8 Million USD	11.19%
1994 Q4	47.92 Million USD	-18.21%
1994 FY	47.92 Million USD	50.72%
1993 Q3	30.4 Million USD	-15.56%
1993 Q2	36 Million USD	60.0%
1993 Q1	22.5 Million USD	-14.12%
1993 FY	31.8 Million USD	21.37%
1993 Q4	31.8 Million USD	4.61%
1992 Q3	20.9 Million USD	51.45%
1992 Q1	11.5 Million USD	-18.44%
1992 Q4	26.2 Million USD	25.36%
1992 FY	26.2 Million USD	85.82%
1992 Q2	13.8 Million USD	20.0%
1991 Q3	13 Million USD	9.24%
1991 Q4	14.1 Million USD	8.46%
1991 FY	14.1 Million USD	10.16%
1991 Q1	10.3 Million USD	-19.53%
1991 Q2	11.9 Million USD	15.53%
1990 FY	12.8 Million USD	113.33%
1990 Q3	8.8 Million USD	25.71%
1990 Q4	12.8 Million USD	45.45%
1990 Q2	7 Million USD	20.69%
1990 Q1	5.8 Million USD	-3.33%
1989 FY	6 Million USD	-53.49%
1989 Q4	6 Million USD	-7.69%
1989 Q3	6.5 Million USD	0.0%

Peer Total Liabilities Comparison of Biogen Inc.

Name	Total Liabilities	Total Liabilities Difference
Amgen Inc.	90.92 Billion USD	86.752%
AstraZeneca PLC	61.95 Billion USD	80.557%
Gilead Sciences, Inc.	39.37 Billion USD	69.409%
MIRA Pharmaceuticals, Inc.	558.09 Thousand USD	-2158198.647%
Scilex Holding Company	274.24 Million USD	-4292.172%
Scilex Holding Company	274.24 Million USD	-4292.172%

Global Stocks Search

Biogen Inc. (BIIB)

Total Liabilities Summary of Biogen Inc.

Annual Total Liabilities Chart of Biogen Inc. (2023 - 1989)

Historical Annual Total Liabilities of Biogen Inc. (2023 - 1989)

Peer Total Liabilities Comparison of Biogen Inc.